Intratumoral Chlorine Dioxide Ablation Technology – 200-Patient Clinical Study (Hainan, China)
(For Hainan Boao Evergrande International Hospital)
Note:
This form is for pre-registration only. It is used to evaluate preliminary eligibility and to notify you when the clinical study officially begins.
Pre-registration does not guarantee enrollment or constitute a medical commitment.
(All items must be checked)
I understand the study will be conducted at Hainan Boao Evergrande International Hospital.*
I understand Ethics Committee and provincial filing are required; estimated start: 1–3 months.*
I understand participation is free, but two PET-CT scans cost USD 6,000.*
I understand the study does not guarantee treatment success; the goal is 95% full tumor necrosis after four sessions.*
I understand the study includes solid tumors only, with ≤10 lesions.*
I understand that for one year after signing consent, any active tumor can receive free additional injections at the hospital.*
I agree to provide complete imaging data (CT/MRI/PET-CT) once the study begins.*
Please upload your most recent medical reports (if available):
• Imaging: CT / MRI / PET-CT
• Pathology report
• Ultrasound (for superficial tumors)
• Any relevant diagnostic document
I understand that:
This form is for pre-registration only and does not guarantee study enrollment.
My information will be used solely for future contact regarding this study.
My data will be protected under Chinese and international privacy regulations.
I may request deletion of my information at any time.
Yes, I have read and agree to the above terms.*
